Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer
This completed study reports on developing mouse models of breast cancer using tissue samples from women with breast cancer. The work focuse…
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy? [NA]
This clinical trial update highlights factors influencing the efficacy of neoadjuvant chemotherapy for breast cancer.
-
CLINICAL_TRIALS research · 2018-05-03Clinical Trial Update: Preoperative Massage in Breast Surgery Patients [NA]
A completed clinical trial evaluating preoperative massage for anxiety in breast surgery patients; the update does not provide trial results…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Art Therapy for Pain Relief in Breast Cancer Patients
This clinical trial evaluates art therapy as a non-pharmacologic approach to relieve pain in breast cancer patients; the current status is U…
-
FDA approval · 2018-04-30FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
The FDA approved Mylan Institutional LLC's original application for a generic docetaxel anhydrous product (ANDA208859).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI [Phase 2]
Phase 2 study of fulvestrant with or without everolimus in postmenopausal, hormone-receptor–positive metastatic breast cancer resistant to a…
-
CLINICAL_TRIALS research · 2018-04-30Clinical Trial Update: Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
This clinical trial investigates detecting circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in peripheral blood to develop an early-…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy [NA]
Clinical trial evaluating the efficacy of an intraoperative gamma camera with lymphoscintigraphy to identify sentinel lymph nodes in breast …
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors [NA]
This record notes the completion of a clinical trial evaluating a targeted eHealth intervention to reduce fear of recurrence among breast ca…
-
FDA approval · 2018-04-27FDA Approved: EXEMESTANE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s generic Exemestane as an original ANDA approval (ANDA 210323).
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors [NA]
This clinical trial update describes a completed study evaluating coaches of older adults to support cancer care and health behaviors. The s…
-
CLINICAL_TRIALS trial_result · 2018-04-26Clinical Trial Update: Partnership for Healthy Seniors [NA]
A completed clinical trial update from Johns Hopkins Bloomberg School of Public Health covering cancers of the breast, colon, rectum, cervix…
-
CLINICAL_TRIALS research · 2018-04-25Clinical Trial Update: Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study comparing Letrozole plus low-dose metronomic capecitabine versus EC-T (epirubicin/cyc…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1]
This update reports results from a Phase 1 study evaluating the combination of docetaxel and imatinib mesylate in patients with locally adva…
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen
Clinical trial update examining CYP2D6 genotyping and phenotyping in breast cancer patients treated with tamoxifen. The status is listed as …
-
CLINICAL_TRIALS research · 2018-04-24Clinical Trial Update: Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment [NA]
This is a completed clinical trial update evaluating breast reconstruction with an acellular dermal matrix in the setting of breast cancer t…
-
FDA approval · 2018-04-23FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to introduce a Kisqali (ribociclib) and Femara (letrozole) co-packaged product, enabling combined us…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression [Phase 2]
Phase 2 trial evaluating trastuzumab in combination with standard chemotherapy given before surgery in breast cancer patients with low HER2 …
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases [Phase 2]
Phase 2 trial evaluating irinotecan plus temozolomide in patients with breast cancer who previously had brain metastases. Results from the s…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer [Phase 2]
A Phase 2 trial evaluating buparlisib (BKM120) in combination with tamoxifen for HR-positive, HER2-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer [Phase 2]
Phase II trial of bortezomib and doxorubicin in metastatic breast cancer was terminated; results posted in 2018.
-
CLINICAL_TRIALS other · 2018-04-20Clinical Trial Update: Cryoablation of Small Breast Tumors in Early Stage Breast Cancer [NA]
This document provides an update on a clinical trial evaluating cryoablation for small breast tumors in patients with early-stage breast can…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion [Phase 1]
Phase 1 study assessing the effect of intraoperative intravenous lidocaine infusion on serum opiorphin levels in patients with breast cancer…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction [NA]
This clinical trial update reports on a study evaluating perfusion and patient satisfaction after nipple-areola mastectomy with immediate re…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer
A completed Stanford University trial comparing contrast-enhanced digital mammography with contrast-enhanced breast MRI for imaging in breas…